|
|
Article: Array, Callisto Enter Alliance To Discover New Antibiotics.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Array BioPharma Inc. entered a collaboration with Callisto Pharmaceuticals Inc. for the development of a new class of antibiotics, a deal that would mean 50-50 ownership of any resulting drugs.
New York-based Callisto, which is privately held, will provide a cellular-based assay to Array for screening against ArrayEs lead generation library to identify compounds that will kill or weaken bacteria and eliminate them from the body.
oOur role is to develop a small-molecule drug against their target, and the first thing Array will do is screen our lead generation library of compounds against their target,o said Tricia Haugato, corporate ...